grant

Development of recombinant rsolCD39-PSGL as a novel therapeutic with anti-thrombotic and anti-inflammatory effects [ 2008 - 2009 ]

Also known as: New drug to combat blood clotting and inflammation

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/520697]

Researchers: Prof Harshal Nandurkar (Principal investigator) ,  Prof Anthony D'Apice Prof Peter Cowan

Brief description Heart disease and stroke are due to a narrowing of arteries followed by occlusion, due a combination of clot formation initiated by platelet clumping, and inflammation surrounding the vessel wall. The currently available drugs are often limited by the adverse reaction of bleeding. We will investigate the efficiency of a new drug to prevent clot formation and inflammation.

Funding Amount $AUD 186,367.60

Funding Scheme NHMRC Development Grants

Notes Development Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857